Zika Virus Replicons for Drug Discovery

EBioMedicine

Volumn 12, Issue , 2016, Pages 156-160

  Xie, Xuping ^a   Zou, Jing ^a   Shan, Chao ^a   Yang, Yujiao ^a,b   Kum, Dieudonné Buh ^a,c   Dallmeier, Kai ^c   Neyts, Johan ^c   Shi, Pei Yong ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SOUTHWEST UNIVERSITY   (China)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Drug discovery; Flavivirus; Replicon; Zika

Indexed keywords

ADENOSINE DERIVATIVE; NITD 008; NONSTRUCTURAL PROTEIN 4B; RENILLA LUCIFERIN 2 MONOOXYGENASE; UNCLASSIFIED DRUG; VIRUS RNA; ANTIVIRUS AGENT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA TRANSCRIPTION; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE; ZIKA VIRUS; CELL CULTURE TECHNIQUE; CELL LINE; DRUG DEVELOPMENT; DRUG EFFECTS; GENE EXPRESSION; PHYSIOLOGY; PRECLINICAL STUDY; PROCEDURES; REPLICON; REPORTER GENE; VIROLOGY; VIRUS GENOME; ZIKA VIRUS INFECTION;

ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; CELL LINE; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; GENES, REPORTER; GENOME, VIRAL; HUMANS; REPLICON; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84992646605     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.09.013     Document Type: Article

References (26)

1. Blight, K.J., Kolykhalov, A.A., Rice, C.M., Efficient initiation of HCV RNA replication in cell culture. Science 290 (2000), 1972–1974.
2. Corver, J., Lenches, E., Smith, K., Robison, R.A., Sando, T., Strauss, E.G., Strauss, J.H., Fine mapping of a cis-acting sequence element in yellow fever virus RNA that is required for RNA replication and cyclization. J. Virol. 77 (2003), 2265–2270.
3. Deng, Y.-Q., Zhang, N.-N., Li, C.-F., Tian, M., Hao, J.-N., Xie, X., Shi, P.-Y., Qin, C.-F., Adenosine analog NITD008 is a potent inhibitor of Zika virus. Open Forum Infect. Dis., 2016 (doi: 296 10.1093/ofid/ofw175).
4. Gehrke, R., Ecker, M., Aberle, S.W., Allison, S.L., Heinz, F.X., Mandl, C.W., Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J. Virol. 77 (2003), 8924–8933.
5. Hahn, C.S., Hahn, Y.S., Rice, C.M., Lee, E., Dalgarno, L., Strauss, E.G., Strauss, J.H., Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J. Mol. Biol. 198 (1987), 33–41.
6. Harvey, T.J., Liu, W.J., Wang, X.J., Linedale, R., Jacobs, M., Davidson, A., Le, T.T., Anraku, I., Suhrbier, A., Shi, P.Y., et al. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 78 (2004), 531–538.
7. Jones, C.T., Patkar, C.G., Kuhn, R.J., Construction and applications of yellow fever virus replicons. Virology 331 (2005), 247–259.
8. Khromykh, A.A., Westaway, E.G., Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71 (1997), 1497–1505.
9. Khromykh, A.A., Meka, H., Guyatt, K.J., Westaway, E.G., Essential role of cyclization sequences in flavivirus RNA replication. J. Virol. 75 (2001), 6719–6728.
10. Li, S.H., Li, X.F., Zhao, H., Deng, Y.Q., Yu, X.D., Zhu, S.Y., Jiang, T., Ye, Q., Qin, E.D., Qin, C.F., Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2. Virol. J., 10, 2013, 64.
11. Lindenbach, B.D., Murray, C.L., Thiel, H.J., Rice, C.M., Flaviviridae. Knipe, D.M., Howley, P.M., (eds.) Fields Virology, 6th, vol. 1, 2013, Lippincott William & Wilkins, Philadelphia, 712–746.
12. Lo, M.K., Tilgner, M., Bernard, K.A., Shi, P.Y., Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3′ untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication. J. Virol. 77 (2003), 10004–10014.
13. Lo, M.K., Tilgner, M., Shi, P.Y., Potential high-throughput assay for screening inhibitors of West Nile virus replication. J. Virol. 77 (2003), 12901–12906.
14. Lo, M.K., Shi, P.Y., Chen, Y.L., Flint, M., Spiropoulou, C.F., In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses. Antivir. Res. 130 (2016), 46–49.
15. Manzano, M., Reichert, E.D., Polo, S., Falgout, B., Kasprzak, W., Shapiro, B.A., Padmanabhan, R., Identification of cis-acting elements in the 3′-untranslated region of the dengue virus type 2 RNA that modulate translation and replication. J. Biol. Chem. 286 (2011), 22521–22534.
16. Ng, C.Y., Gu, F., Phong, W.Y., Chen, Y.L., Lim, S.P., Davidson, A., Vasudevan, S.G., Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antivir. Res. 76 (2007), 222–231.
17. Puig-Basagoiti, F., Tilgner, M., Forshey, B.M., Philpott, S.M., Espina, N.G., Wentworth, D.E., Goebel, S.J., Masters, P.S., Falgout, B., Ren, P., et al. Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob. Agents Chemother. 50 (2006), 1320–1329.
18. Qing, M., Liu, W., Yuan, Z., Gu, F., Shi, P.Y., A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antivir. Res. 86 (2010), 163–171.
19. Shan, C., Xie, X., Barrett, A.D.T., Garcia-Blanco, M.A., Tesh, R.B., Vasconcelos, P.F.d.C., Vasilakis, N., Weaver, S.C., Shi, P.-Y., Zika virus: diagnosis, therapeutics, and vaccine. ACS Infect. Dis. 2 (2016), 170–172.
20. Shan, C., Xie, X., Muruato, A.E., Rossi, S.L., Roundy, C.M., Azar, S.R., Yang, Y., Tesh, R.B., Bourne, N., Barrett, A.D., et al. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19 (2016), 891–900.
21. Shi, P.Y., Strategies for the identification of inhibitors of West Nile virus and other flaviviruses. Curr. Opin. Investig. Drugs 3 (2002), 1567–1573.
22. Shi, P.Y., Tilgner, M., Lo, M.K., Construction and characterization of subgenomic replicons of New York strain of West Nile virus. Virology 296 (2002), 219–233.
23. Wang, Q.Y., Kondreddi, R.R., Xie, X., Rao, R., Nilar, S., Xu, H.Y., Qing, M., Chang, D., Dong, H., Yokokawa, F., et al. A translation inhibitor that suppresses dengue virus in vitro and in vivo. Antimicrob. Agents Chemother. 55 (2011), 4072–4080.
24. Xie, X., Wang, Q.Y., Xu, H.Y., Qing, M., Kramer, L., Yuan, Z., Shi, P.Y., Inhibition of dengue virus by targeting viral NS4B protein. J. Virol. 85 (2011), 11183–11195.
25. Xie, X., Zou, J., Wang, Q.Y., Noble, C.G., Lescar, J., Shi, P.Y., Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus. Virology 450-451 (2014), 250–257.
26. Yin, Z., Chen, Y.L., Schul, W., Wang, Q.Y., Gu, F., Duraiswamy, J., Kondreddi, R.R., Niyomrattanakit, P., Lakshminarayana, S.B., Goh, A., et al. An adenosine nucleoside inhibitor of dengue virus. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20435–20439.